Gain Therapeutics GANX
NASDAQ GANX
$1.26 -0.03 (-2.33%)
At close: Oct 23, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Property, Plant & Equipment (Net) (2020 - 2026)

Updated

Gain Therapeutics (GANX) recorded Property, Plant & Equipment (Net) of $47,026 in Q2 2026, down 51.1% from $96,190 a year earlier and down 13.6% from the prior quarter.

Analysis

Gain Therapeutics (GANX) Property, Plant & Equipment (Net) (2020 - 2026) Analysis & Trends

At the end of FY2025, Gain Therapeutics reported Property, Plant & Equipment (Net) of $74,916, down 27.7% from FY2024.

  • Annual Property, Plant & Equipment (Net) has declined for three straight years, though with a five-year compound annual growth rate of 20.4% (FY2020 to FY2025).
  • Across earlier years, Property, Plant & Equipment (Net) came in at $103,619 in FY2024 (-17.7%), $125,962 in FY2023 (-12.8%), $144,379 in FY2022 (+36.2%) and $105,986 in FY2021 (+257.7%).
  • The Q2 2026 figure is the lowest quarterly Property, Plant & Equipment (Net) since Q4 2020.
  • On a year-over-year basis, Property, Plant & Equipment (Net) has declined for 13 consecutive quarters, with an average decline of 26.3% over the last eight quarters.
  • Peak year-over-year performance for Property, Plant & Equipment (Net) in the last five years was growth of 257.7% in Q4 2021, against a decline of 51.1% in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $54,435 (Q1 2026), $74,916 (Q4 2025) and $85,572 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 29.29 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 24.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 5.80 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 25.74 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 10.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 13.62 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 8.55 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 5.83 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 19.03 Bn
10 Gain Therapeutics 54.61 Mn -4.68 Mn - 47,026.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 47,026.00
Mar 31, 2026 54,435.00
Dec 31, 2025 74,916.00
Sep 30, 2025 85,572.00
Jun 30, 2025 96,190.00
Mar 31, 2025 97,509.00
Dec 31, 2024 103,619.00
Sep 30, 2024 119,610.00
Jun 30, 2024 123,930.00
Mar 31, 2024 111,909.00
Dec 31, 2023 125,962.00
Sep 30, 2023 127,393.00
Jun 30, 2023 138,556.00
Mar 31, 2023 144,636.00
Dec 31, 2022 144,379.00
Sep 30, 2022 136,717.00
Jun 30, 2022 138,909.00
Mar 31, 2022 106,725.00
Dec 31, 2021 105,986.00
Sep 30, 2021 103,050.00
API Access

Gain Therapeutics Property, Plant & Equipment (Net) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=property-plant-and-equipment-net&ticker=GANX&period=max&api_key=YOUR_API_KEY